The concern of generic challenges website has long loomed over copyright’s iconic drug, PDE5 Inhibitor, raising questions about the future of related medicinal portfolios. While initial periods saw substantial gains, the exclusivity end has allowed the door for discounted substitutes, potentially diminishing profitability and presenting a real ri